Search Results
Results found for "Glaxo Inc"
- Our History | Dr. GPCR Ecosystem
Marc Caron Tribute Episodes ( #100 , #101 & #102 ), featuring over 30 expert guests , including Dr.
- Gunnar Schulte: Frizzled Receptors and the GPCR Identity Question | Dr. GPCR Ecosystem
For Schulte, the scarcity of pharmacological tools is not just a technical inconvenience — it is the His lab investigates the molecular mechanisms of frizzled receptor activation, including G-protein coupling old adenosine receptor times, that we have the small molecule available and get crystal clear tenfold increase
- David Gloriam: Orphan Receptors, GPCRDB, and the Data Revolution in GPCR Pharmacology | Dr. GPCR Ecosystem
His group contributed to the de-orphanization of GPR139 and GPR55, including the identification of sub-nanomolar
- 14-Day Trial — Dr. GPCR University | Full Access for $49 | Dr. GPCR Ecosystem
GPCR-relevant society memberships cost $200–$600+ per year and offer a fraction of what University includes
- Dr. Kenneth A. Jacobson | Dr. GPCR Ecosystem
His numerous awards include: 2008 Sato Award; 2009 Medicinal Chemistry Hall of Fame (American Chemical
- Joseph Kim: Structural Biology and Drug Discovery at GPCRs | Dr. GPCR Ecosystem
Kim describes a personal inclination toward challenging research areas. GPCR Drug Discovery Is Increasingly Structural Modern GPCR drug discovery increasingly integrates structural Showing those structures to my colleagues—and realizing that the experiment actually worked—was incredibly
- Terry Hébert | Dr. GPCR Ecosystem
remotely; the continuity of receptor pharmacology work already in the pipeline before the shutdown, including
- Dr. Randy Hall | Dr. GPCR Ecosystem
Randy has received a number of research prizes, including the PhRMA New Investigator Award, the Distinguished
- Terry Hebert: How Cellular Background and Localization Influence GPCR Function | Dr. GPCR Ecosystem
The discussion also explores GPCRs beyond the cell surface — including caged ligands designed to drug Hebert argues this was not a failure of the concept but of incomplete pharmacological characterization Hebert's lab is transitioning to iPSC-derived cardiomyocytes and fibroblasts, including cells from patients
- Dr. Richard Premont | Dr. GPCR Ecosystem
) and arrestins as GPCR regulators and as mediators of distinct signaling pathways through partners including In our work, we utilize methods including structural biology and proteomics, molecular biology and biochemical
- A Brief History of allosteric modulation with Dr. Arthur Christopoulos | Dr. GPCR Ecosystem
novel paradigms of drug action at GPCRs, particularly allosteric modulation and biased agonism, and incorporates Professor Christopoulos has over 360 publications, including in leading international journals such as He has also been the recipient of multiple awards, including the John J. GPCR AI Summary Quick recap Yamina and Arthur discussed Arthur's career journey in pharmacology, including Arthur shared his career journey, including his collaboration with Patrick Sexton and Jim Burch, and
- Qing Fan: Inside the Architecture of Class C GPCRs | Dr. GPCR Ecosystem
calcium-sensing receptor, the molecular mechanisms governing their activation and regulation remain incompletely with their respective subunits, leading Fan to propose they are necessary structural components - not incidental spasticity in multiple sclerosis and spinal cord injury, but it carries significant side effects - including aha" moments that shaped a career - from MHC antigen presentation to the cryo-EM revolution 29:55 - Increasing
- Charlotte Crauwels: Designing Hybrid GPCRs with Computational Protein Engineering | Dr. GPCR Ecosystem
Successful GPCR research increasingly depends on close collaboration between these two domains. If the experimental data is poorly annotated or incomplete, the computational predictions will not be The terminology used in the literature is inconsistent.
- Elva Zhao: G Protein Regulation and Biased Signaling at the GLP-1 Receptor | Dr. GPCR Ecosystem
conditioning around deference, the general insecurity of early-stage training, and the fear of appearing incompetent
- Silvio Gutkind: When GPCRs Drive Cancer | Dr. GPCR Ecosystem
Current focuses include GαQ-driven uveal melanoma, GαS mutations across pancreatic, colon, and appendix Most large cancer sequencing panels now include these genes — though most oncologists are still unsure That insight is now powering focal adhesion kinase–directed clinical trials, including one Dr.
- Masha Niv: Bitter Taste Receptors and the Drug Discovery Blind Spot | Dr. GPCR Ecosystem
distinction opened space for a more nuanced view of bitter compounds in nutrition and pharmacology - including screen extensively for efficacy, safety, and pharmacokinetics - but bitterness prediction was rarely incorporated
- Dr. Arthur Christopoulos | Dr. GPCR Ecosystem
novel paradigms of drug action at GPCRs, particularly allosteric modulation and biased agonism, and incorporates Professor Christopoulos has over 360 publications, including in leading international journals such as He has also been the recipient of multiple awards, including the John J. They shared their unconventional approaches to research, including the creation of a critical mass of The conversation highlighted ongoing challenges within universities, including resistance to change and
- EARNEST Panel: Can AI Accelerate GPCR Drug Discovery? | Dr. GPCR Ecosystem
early cloning of GPCRs in the mid-1980s and has since pushed the boundaries of GPCR biochemistry — including Most pharmacology datasets aren't useless for ML; they're incomplete. Buffers, incubation temperatures, time points, co-expression conditions, the specific Emax reference
- Dr. Graeme Milligan | Dr. GPCR Ecosystem
His experience also includes translating knowledge generated into the selection of targets, screening co-founder of both Caldan Therapeutics (2015) which discovers novel therapeutics for metabolic diseases including Type 2 Diabetes and other indications including non-alcoholic steatohepatitis (NASH) and inflammatory
- Lauren Solano: Mapping Careers Beyond the Bench | Dr. GPCR Ecosystem
communicating across technical audiences — and introduces concrete tools for self-assessment and exploration, including Function over title Job titles in biotech are often creative and inconsistent — a medical science liaison
- Dr. Aylin Hanyaloglu | Dr. GPCR Ecosystem
research focuses on understanding the fundamental cell biological mechanisms regulating GPCR activity, including
- Dr. John Janetzko | Dr. GPCR Ecosystem
My postdoc work has made use of several techniques including various mass spectrometry approaches, single Besides research, I am passionate about teaching, science communication and making research more inclusive He participated in various academic competitions, including math, physics, and chemistry contests. He also discussed the challenges of choosing between job offers, including considering his wife's career
- Self-Learning, Collaboration, and Delegation in Science with Dr. Badr Sokrat | Dr. GPCR Ecosystem
Badr worked in various science labs, including Dr. Christian Badr’s and Dr.
- Chemical Probes for GPCR Imaging and Internalization with Dr. Johannes Broichhagen | Dr. GPCR Ecosystem
His postdoctoral training included research at the École Polytechnique Fédérale de Lausanne (2015–2016
- Dr. Jean-Philippe Pin | Dr. GPCR Ecosystem
and activation mechanism of this family of G protein-coupled receptors using innovative approaches, including
- Irfan Dhanidina, Dr. Kathleen Caron and Dr. Lauren Slosky | Dr. GPCR Ecosystem
In my role at Orion Biotechnology, I work at the intersection of science and business, which includes Caron has received numerous awards including a Burroughs Wellcome Fund Career Award in the Biomedical Slosky’s work has been recognized through several travel and research awards, including the William James Slosky is passionate about training the next generation of scientists and increasing diversity, equity , and inclusion in science.
- Custom Molecules, Fluorescent Probes: When Chemists Think Like Biologists with Dr. Maria Majellaro from Celtarys | Dr. GPCR Ecosystem
Majellaro Her decisions, often made intuitively rather than analytically, have led to key inflection points—including The company works with clients from pharma, CROs, and academia, including MD Anderson and several leading
- Terms and Conditions | Dr. GPCR Ecosystem
Such Services includes also access to the Website, and to all software (including the Software, as defined Customer understands that the operation of the Services, including Customer Information, may involve hardware device from the use of the Services; the content, actions, or inactions of third parties, including SOME STATES DO NOT ALLOW THE EXCLUSION OF IMPLIED WARRANTIES OR LIMITATION OF LIABILITY FOR INCIDENTAL product and service providers, and affiliates harmless from any liability, loss, claim and expense, including
- Graciela Pineyro: Resilience, Lab Life, and the Zoom Effect | Dr. GPCR Ecosystem
GPCR Podcast; her earlier episode covers her scientific profile in depth, including her research trajectory whole conversation: the structural shifts forced by the shutdown — planned reflection, remote meeting inclusion
- Maria Waldhoer: Pharmacological Fingerprints and the Limits of Bias | Dr. GPCR Ecosystem
academic group in Graz, she spent six and a half years at Novo Nordisk in early drug discovery, focused on incretin With comorbidities and aging populations driving drug discovery, the one-receptor-one-drug frame is increasingly eyeing industry or biotech 42:35 — On starting a GPCR company: why not too early 57:30 — Aha moments, including




























